The initial excitement came from the realization that Hsp90 acts as a chaperone to stabilize almost all key signaling molecules in parallel signaling pathways and, therefore, the inhibition of Hsp90 may turn out to have a one-fell-swoop effect, both blocking tumor progression and preventing drug resistance. The gene discussed is HSP90AB1; the disease is neoplasm.